R
Revolution Medicines, Inc. (RVMD)
NMS – Real Time Price. Currency in USD
182.08
+3.91 (2.19%)
At close: Jun 26, 2026, 4:00 PM EDT
182.60
+0.52 (0.29%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
182.08
+3.91 (2.19%)
At close: Jun 26, 2026, 4:00 PM EDT
182.60
+0.52 (0.29%)
After-hours: Jun 26, 2026, 7:53 PM EDT
No Data
There are no news for this stock.
Cash reserves $440.9M barely cover the upcoming debt maturities $437.3M
Total current assets $2.0B exceed Total current liabilities $289.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-36.5x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$355.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.80 | 6.05 | 10 | |
| Quick ratio | 6.80 | 5.63 | 10 | |
| Debt to Equity | 0.29 | 0.30 | 8.0 | |
| Debt to Assets | 0.19 | 1.04 | 8.0 | |
| Interest coverage | -36.50 | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 35M | 12M | N/A | N/A | N/A |
| Gross Profit | 26M | 2M | -12M | -17M | -17M |
| Operating Income | -258M | -487M | -690M | -1.18B | -1.39B |
| Net Income | -249M | -436M | -600M | -1.13B | -1.37B |
| EBITDA | -249M | -478M | -678M | -1.17B | -1.37B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -49.67 | 1.0 |
| Next quarter | N/A | -22.78 | 1.0 |
| Current year | N/A | -33.63 | 1.0 |
| Next year | 680.88 | 31.04 | 10 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -24.36 | -23.11 | -28.79 | 3.3 |
| Y/Y | 999 | -112.63 | -102.64 | -79.91 | 3.3 |
| 3y average | 277.25 | -67.15 | -28.07 | -57.22 | 3.3 |
| 5y average | 164.1 | -61.46 | -26.38 | -54.78 | 3.3 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | Narrow | 2.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 2.0 |
| Weighted average score | 2.6 | |